Ergovasan

Recall | Medicines | 20/03/2014

The marketing authorization holder informed its supplied customers in a letter dated 19.03.2014 that underfilling of the15 ml package size had been detected. This is not a case of underfilling during production, but of evaporation of the alcohol due to drip fittings not fitting tightly. This evaporation subsequently leads to a concentration of the active ingredient of up to 85%.

Name of the medicinal product Ergovasan 2 mg/ml -Tropfen
Marketing authorisation number(s) 1-19270
Marketing authorisation holder WABOSAN Arzneimittelvertriebs GmbH
Batch number(s) 08
Expiry date 09/03/2019
Classification of the recall2
BASG reference number INS - 640.001 - 1048
Email

Further inquiry note